scholarly article | Q13442814 |
P2093 | author name string | Masoud Soleimani | |
Hoorieh Soleimanjahi | |||
Taravat Bamdad | |||
Hajar Estiri | |||
Azra Kenarkoohi | |||
Mohammad Hadi Razavi-Nikoo | |||
P2860 | cites work | Production and titration of lentiviral vectors | Q85181832 |
Global cancer statistics | Q22241238 | ||
Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 | ||
Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
Advances in mesenchymal stem cell-mediated gene therapy for cancer. | Q34135233 | ||
Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases | Q34367266 | ||
Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells | Q34378615 | ||
The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents. | Q34992255 | ||
Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia | Q35579260 | ||
Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells | Q35635000 | ||
Targeted treatments for cervical cancer: a review. | Q36384032 | ||
Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities. | Q36861470 | ||
Mesenchymal stem cells: an emerging tool for cancer targeting and therapy | Q37066661 | ||
Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 | ||
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. | Q37317976 | ||
Recent advances in lentiviral vector development and applications | Q37678176 | ||
Potential implications of mesenchymal stem cells in cancer therapy | Q37852245 | ||
A stable system for the high-titer production of multiply attenuated lentiviral vectors | Q40860697 | ||
Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases | Q41916915 | ||
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. | Q42810754 | ||
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy | Q43100976 | ||
Isolation and characterization of mouse mesenchymal stem cells | Q79635182 | ||
P433 | issue | 4 | |
P921 | main subject | mesenchymal stem cell | Q1922379 |
uterine cervix neoplasm | Q56014502 | ||
P304 | page(s) | 225-231 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Iranian journal of cancer prevention | Q26842272 |
P1476 | title | Efficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor model | |
P478 | volume | 7 |
Search more.